Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 884.96 $ 18.99 (2.19 %)    

Tuesday, 23-Jul-2024 12:20:31 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.89 $ 2.14 (0.45 %)
DIA $ 404.93 $ 0.57 (0.14 %)
SPY $ 556.16 $ 1.47 (0.27 %)
TLT $ 92.98 $ 0.11 (0.12 %)
GLD $ 222.33 $ 0.06 (0.03 %)
$ 865.97
$ 869.60
$ 884.50 x 100
$ 967.37 x 272
$ 865.05 - $ 887.32
$ 443.25 - $ 966.10
2,854,300
na
782.66B
$ 0.58
$ 127.50
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 04-29-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-27-2018 03-31-2018 10-Q
26 02-20-2018 12-31-2017 10-K
27 10-27-2017 09-30-2017 10-Q
28 07-28-2017 06-30-2017 10-Q
29 05-01-2017 03-31-2017 10-Q
30 02-21-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 07-30-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-19-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 07-28-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Novo's Weight-Loss Drug Wegovy Receives UK...
07/23/2024 14:41:27

- Bloomberg

market-whales-and-their-recent-bets-on-lly-options
Market Whales and Their Recent Bets on LLY...
07/23/2024 13:46:58

bidens-exit-from-presidential-race-yet-another-curveball-for-equity-investors-analysts
Biden's Exit From Presidential Race 'Yet A...
07/22/2024 18:54:41

President Biden's decision to drop out may harm healthcare and create market volatility. Kamala Harris could defend his rec...

anaptysbio-investigational-arthritis-drug-might-have-better-efficacy-profile-than-eli-lillys-analyst
AnaptysBio Investigational Arthritis Drug ...
07/22/2024 18:53:08

HC Wainwright initiated coverage on AnaptysBio with a Buy rating and a $55 price target. AnaptysBio focuses on immunology thera...

oral-weight-loss-drugs-vs-injections---pills-are-promising-yet-challenging-frontier
Oral Weight Loss Drugs Vs. Injections - Pi...
07/22/2024 17:42:06

Pharmaceutical giants like Roche, Eli Lilly, Novo Nordisk, and Pfizer are racing to develop oral weight loss medications. These...

craze-for-ozempic-and-zepbound-for-weight-loss-leave-diabetic-patients-without-critical-glp-1-medications
Craze For Ozempic And Zepbound For Weight ...
07/19/2024 17:32:11

Skyrocketing demand for GLP-1 medications for weight loss is causing shortages, impacting type 2 diabetics. While some insurers...

Core News & Articles
Benzinga Market Summary: Microsoft And Air...
07/19/2024 14:31:35

eli-lillys-famed-weight-loss-drug-zepbound-scores-chinese-approval
Eli Lilly's Famed Weight Loss Drug Zepboun...
07/19/2024 11:25:59

Eli Lilly's Tirzepatide approved by China's NMPA for long-term weight management, targeting adults with specific BMI cr...

palantir-netflix-dominos-pizza-eli-lilly-tesla-why-these-5-stocks-are-on-investors-radars-today
Palantir, Netflix, Domino's Pizza, Eli Lil...
07/19/2024 02:00:02

The Dow Jones Industrial Average dropping nearly 1.3% to 40,665.03 on Thursday, the S&P 500 and Nasdaq declined as well.

johnson--johnson-prioritizes-sustainable-growth-in-ma-amid-sector-diversification-says-analyst
Johnson & Johnson Prioritizes Sustainable ...
07/18/2024 18:51:35

Johnson & Johnson reports Q2 EPS of $2.82, up 10.2% YoY, beating expectations. Analysts foresee strong MedTech markets ahea...

vix-stages-double-digit-spike-as-risk-off-takes-over-chipmakers-fail-to-rebound-weight-loss-giants-eli-lilly-novo-tumble-whats-driving-markets-thursday
VIX Stages Double-Digit Spike As Risk Off ...
07/18/2024 18:05:28

It’s another risk-off day on Wall Street, with all major U.S. indices trading in the red. The CBOE Volatility Index (VIX), ofte...

whats-going-on-with-eli-lilly-and-company-shares-thursday
What's Going On With Eli Lilly And Company...
07/18/2024 16:32:56

Eli Lilly and Company stock is moving lower on Thursday on possible continued weakness after recent weight loss data from Roche.

tevas-migraine-treatment-found-effective-for-children-as-young-as-6
Teva's Migraine Treatment Found Effective ...
07/18/2024 16:06:36

Teva Pharmaceutical's Phase 3 SPACE study reveals Ajovy's significant efficacy in preventing episodic migraines in chil...

pfizer-and-roche-advance-on-their-weight-loss-drug-journeys
Pfizer And Roche Advance On Their Weight L...
07/17/2024 14:48:52

After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, P...

obesity-drugs-focused-stocks-tumble-on-wednesday---whats-going-on-with-eli-lilly-novo-nordisk-viking-therapeutics-structure-therapeutics
Obesity-Drugs Focused Stocks Tumble On Wed...
07/17/2024 14:47:40

Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996...

Core News & Articles
Benzinga Market Summary: Chip Stocks Fall ...
07/17/2024 13:33:51

jim-cramer-says-dont-sell-match-group-youve-just-got-a-very-very-smart-investor-in-there
Jim Cramer Says Don't Sell Match Group: 'Y...
07/17/2024 12:55:11

Jim Cramer doesn't favor Fortinet, but owns Palo Alto Networks for charity. Air Products not doing well due to better run c...

senate-to-review-novo-nordisks-levemir-insulin-discontinuation
Senate To Review Novo Nordisk's Levemir In...
07/16/2024 17:49:39

Novo Nordisk will meet with U.S. Senate aides to discuss the discontinuation of Levemir, its long-acting insulin, amid concerns...

eli-lilly-and-cos-options-a-look-at-what-the-big-money-is-thinking
Eli Lilly and Co's Options: A Look at What...
07/16/2024 14:31:21

this-analyst-sees-potential-downside-in-eli-lilly-adjusts-model-for-acquired-iprd-charges
This Analyst Sees Potential Downside In El...
07/15/2024 17:13:12

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)
07/30/2024 Rivian Automotive, Inc. (RIVN)
07/30/2024 Hertz Global Holdings, Inc. (HTZ)
08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)